메뉴 건너뛰기




Volumn 6, Issue 1, 2003, Pages

Prevention of breast cancer by recapitulation of pregnancy hormone levels

Author keywords

Breast cancer; Estrogen; Pregnancy; Prevention; Progesterone

Indexed keywords

CARCINOGEN; ESTROGEN; ESTROGEN RECEPTOR; GESTAGEN; TAMOXIFEN;

EID: 85010723407     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr750     Document Type: Note
Times cited : (9)

References (13)
  • 3
    • 0033515086 scopus 로고    scopus 로고
    • Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy
    • Guzman RC, Yang J, Rajkumar L, Thordarson G, Chen X, Nandi S: Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy. Proc Natl Acad Sci USA. 1999, 96: 2520-2525. 10.1073/pnas.96.5.2520.
    • (1999) Proc Natl Acad Sci USA , vol.96 , pp. 2520-2525
    • Guzman, R.C.1    Yang, J.2    Rajkumar, L.3    Thordarson, G.4    Chen, X.5    Nandi, S.6
  • 4
    • 0033032912 scopus 로고    scopus 로고
    • Protective effects of pregnancy and lactation against N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats
    • Yang J, Yoshizawa K, Nandi S, Tsubura A: Protective effects of pregnancy and lactation against N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats. Carcino-genesis. 1999, 20: 623-628.
    • (1999) Carcino-genesis , vol.20 , pp. 623-628
    • Yang, J.1    Yoshizawa, K.2    Nandi, S.3    Tsubura, A.4
  • 5
    • 0018963856 scopus 로고
    • Susceptibility of the mammary gland to carcinogenesis. II. Pregnancy interruption as a risk factor in tumor incidence
    • Russo J, Russo IH: Susceptibility of the mammary gland to carcinogenesis. II. Pregnancy interruption as a risk factor in tumor incidence. Am J Pathol. 1980, 100: 497-512.
    • (1980) Am J Pathol , vol.100 , pp. 497-512
    • Russo, J.1    Russo, I.H.2
  • 6
    • 0036355979 scopus 로고    scopus 로고
    • Hormone-induced protection against breast cancer
    • Sivaraman L, Medina D: Hormone-induced protection against breast cancer. J Mammary Gland Biol Neoplasia. 2002, 7: 77-92. 10.1023/A:1015774524076.
    • (2002) J Mammary Gland Biol Neoplasia , vol.7 , pp. 77-92
    • Sivaraman, L.1    Medina, D.2
  • 7
    • 0023395635 scopus 로고
    • Biological and molecular bases of mammary carcinogenesis
    • Russo J, Russo IH: Biological and molecular bases of mammary carcinogenesis. Lab Invest. 1987, 57: 112-137.
    • (1987) Lab Invest , vol.57 , pp. 112-137
    • Russo, J.1    Russo, I.H.2
  • 10
    • 0043031110 scopus 로고    scopus 로고
    • Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency
    • Swanson SM, Christov K: Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency. Anticancer Res. 2003, 23: 3207-3213.
    • (2003) Anticancer Res , vol.23 , pp. 3207-3213
    • Swanson, S.M.1    Christov, K.2
  • 11
    • 0035861037 scopus 로고    scopus 로고
    • Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial
    • King MC, Wieand S, Hale K, Lee M, Walsh T, Owens K, Tait J, Ford L, Dunn BK, Costantino J, Wickerham L, Wolmark N, Fisher B: Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial. JAMA. 2001, 286: 2251-2256. 10.1001/jama.286.18.2251.
    • (2001) JAMA , vol.286 , pp. 2251-2256
    • King, M.C.1    Wieand, S.2    Hale, K.3    Lee, M.4    Walsh, T.5    Owens, K.6    Tait, J.7    Ford, L.8    Dunn, B.K.9    Costantino, J.10    Wickerham, L.11    Wolmark, N.12    Fisher, B.13
  • 13
    • 0642314038 scopus 로고    scopus 로고
    • Tamoxifen's impact as a preventive agent in clinical practice and an update on the STAR trial
    • Wickerham DL: Tamoxifen's impact as a preventive agent in clinical practice and an update on the STAR trial. Recent Results Cancer Res. 2003, 163: 87-95.
    • (2003) Recent Results Cancer Res , vol.163 , pp. 87-95
    • Wickerham, D.L.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.